• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $AIXC

    AIxCrypto Holdings Inc.

    Subscribe to $AIXC
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2015

    Exchange: NASDAQ

    Recent Analyst Ratings for AIxCrypto Holdings Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    AIxCrypto Holdings Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Wang Jiawei claimed ownership of 1,658 shares (SEC Form 3)

    3 - AIxCrypto Holdings, Inc. (0001460702) (Issuer)

    12/5/25 7:46:10 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AIxCrypto Holdings Inc. SEC Filings

    View All

    AIxCrypto Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AIxCrypto Holdings, Inc. (0001460702) (Filer)

    1/6/26 1:32:44 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AIxCrypto Holdings Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - AIxCrypto Holdings, Inc. (0001460702) (Filer)

    12/15/25 8:03:33 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by AIxCrypto Holdings Inc.

    DEF 14A - AIxCrypto Holdings, Inc. (0001460702) (Filer)

    12/15/25 10:11:02 AM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form EFFECT filed by AIxCrypto Holdings Inc.

    EFFECT - AIxCrypto Holdings, Inc. (0001460702) (Filer)

    12/12/25 12:15:14 AM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEL AM filed by AIxCrypto Holdings Inc.

    DEL AM - AIxCrypto Holdings, Inc. (0001460702) (Filer)

    12/8/25 1:50:02 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-1 filed by AIxCrypto Holdings Inc.

    S-1 - AIxCrypto Holdings, Inc. (0001460702) (Filer)

    12/3/25 8:48:53 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AIxCrypto Holdings Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    AIxC to Advance Tokenization Strategy with Proposed Strategic Investment in Faraday Future

    LOS ANGELES, Jan. 6, 2026 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ:AIXC) ("AIxC" or the "Company") today announced it has entered into a non-binding term sheet to purchase an initial $10 million tranche of Faraday Future (NASDAQ:FFAI) common stock. This proposed transaction, to be facilitated by an independent third party, represents a strategic deployment of AIxC's blockchain infrastructure and marks a significant step toward the launch of its tokenized Real World Asset (RWA) business. If definitive agreements are executed, AIxC intends to utilize these shares as the foundational asset for its first tokenized equity product. Digitizing the Asset Lifecycle This initiative is designed to harne

    1/6/26 1:39:00 PM ET
    $AIXC
    $FFAI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Manufacturing
    Industrials

    AIxCrypto Establishes UAE Subsidiary and Obtains Web3 Operations License Approval to Support Global AI and Web3 Expansion

    LOS ANGELES and ABU DHABI, UAE , Dec. 23, 2025 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ:AIXC, ", AIxC", or the ", Company", )) today announced the establishment of a regulated Web3-focused subsidiary in the United Arab Emirates ("UAE") and obtained Web3 license approval from local government, subject to final administrative processing. Established in Ras Al Khaimah Innovation City, one of the UAE's most Web3-forward jurisdictions, AIxC's RAK Web3 operations license represents a foundational infrastructure decision—enhancing regulatory certainty, capital access, operational flexi

    12/23/25 9:00:00 AM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AIxC Appoints Andrew Grossman As Head of Legal Where He Will Direct the Company's Legal, Compliance, and Governance Strategy

    LOS ANGELES, Dec. 17, 2025 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ:AIXC, ", AIxC", or ", the Company", )) today announced the appointment of Andrew Grossman as Head of Legal. In this role, Andrew will direct the Company's legal, compliance, and governance functions, managing key areas including SEC disclosures, fund and investment compliance, digital asset and Web3 protocol architecture, and major strategic and commercial agreements. Andrew brings extensive experience in securities regulation, digital asset ecosystem architecture, strategic corporate structuring, IP strategy, a

    12/17/25 1:01:00 AM ET
    $AIXC
    $FFAI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Manufacturing
    Industrials

    YT Jia, Chief Advisor to AIxC Shares Weekly AIxC Investor Update: AIxC Appointed Andrew Grossman as Head of Legal Where he will Take Full Responsibility for the Company's Legal, Compliance, and Governance Framework

    Weekly report is now upgraded to the dual public Company structure weekly update and will report the progress of the Company's dual flywheel businesses every week.LOS ANGELES, Dec. 14, 2025 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ:AIXC, ", AIxC", or ", the Company", )) today shared a weekly business update from YT Jia, Chief Advisor of AIxC and Founder and Global Co-CEO of Faraday Future (NASDAQ:FFAI). "As I serve as Chief Advisor to AIxC, with the Company's day-to-day operations led by its executive management team, I will continue to report the progress of the Company's Dual F

    12/14/25 11:44:00 PM ET
    $AIXC
    $FFAI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Manufacturing
    Industrials

    AIxCrypto Rebrands and Begins Trading Under New Ticker AIXC, Advancing Its "Three Driving Forces" Strategy to Become the No.1 Gateway to AI Web3 and a Bridge Between Web2 and Web3

    The FFAI + AIXC "dual flywheel, dual bridge, dual listing" framework has now been fully established, ushering in a new era of high-speed, two-way empowerment between EAI and Crypto. This approach delivers transformative Web3 value to Web2 while also bringing substantial off-chain Web2 growth into Web3. Breaking boundaries and fostering integration—rather than operating in isolation—is the true future of the Web3 industry.AIxCrypto (AIXC) is now focused on its new "Three Driving Forces" strategy, aimed at becoming the No.1 gateway into the AI Web3 world:BesTrade DeAI Agent & Web3 AI Terminal – the No.1 entry point for Web3 trading, integrating intelligent AI agents with user-facing trading in

    11/20/25 12:36:00 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AIxCrypto Holdings Inc. Leadership Updates

    Live Leadership Updates

    View All

    AIxC Appoints Andrew Grossman As Head of Legal Where He Will Direct the Company's Legal, Compliance, and Governance Strategy

    LOS ANGELES, Dec. 17, 2025 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ:AIXC, ", AIxC", or ", the Company", )) today announced the appointment of Andrew Grossman as Head of Legal. In this role, Andrew will direct the Company's legal, compliance, and governance functions, managing key areas including SEC disclosures, fund and investment compliance, digital asset and Web3 protocol architecture, and major strategic and commercial agreements. Andrew brings extensive experience in securities regulation, digital asset ecosystem architecture, strategic corporate structuring, IP strategy, a

    12/17/25 1:01:00 AM ET
    $AIXC
    $FFAI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Manufacturing
    Industrials